Fundraising Fox

Omniome

San Diego, US · Delaware corporation · 1 known investors

Biotech

Founders & leadership

DS
David S. MullarkeyExecutive Officer, Director
AO
Arnold OliphantExecutive Officer
BN
Boris Nikolic, M.D.Director
KS
Ken Song, M.D., Ph.D.Executive Officer, Director
MY
Michael YiDirector
KP
Kelly PerezExecutive Officer
KK
Kim Kamdar, Ph.D.Director
DZ
Dan ZabrowskiDirector
JM
John Murphy, Ph.D.Executive Officer
DC
David CruikshankDirector

Investors · 1

DCVC (Data Collective)Palo Alto · $5M – $25M

Reported raises · per SEC filings

Form D private placements
▶$60MraisedDec 2019 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dan ZabrowskiDirector
  • Kim Kamdar, Ph.D.Director
  • David S. MullarkeyExecutive Officer, Director
  • Ken Song, M.D., Ph.D.Executive Officer, Director
  • Kelly PerezExecutive Officer
  • Arnold OliphantExecutive Officer
  • David CruikshankDirector
  • Michael YiDirector
  • Catherine LeeExecutive Officer
Offering amount
$60M
Amount sold
$60M
First sale
Nov 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$40MraisedFeb 2019 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David S. MullarkeyExecutive Officer, Director
  • Arnold OliphantExecutive Officer
  • Boris Nikolic, M.D.Director
  • Ken Song, M.D., Ph.D.Executive Officer, Director
  • Michael YiDirector
  • Kelly PerezExecutive Officer
  • Kim Kamdar, Ph.D.Director
  • Dan ZabrowskiDirector
  • John Murphy, Ph.D.Executive Officer
  • David CruikshankDirector
Offering amount
$40M
Amount sold
$40M
First sale
Jun 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.